Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32513665

156 results
Filters applied: . Clear all
Page 1
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.
Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME. Adamsick ML, et al. J Am Soc Nephrol. 2020 Jul;31(7):1384-1386. doi: 10.1681/ASN.2020050589. Epub 2020 Jun 8. J Am Soc Nephrol. 2020. PMID: 32513665 Review. No abstract available.
Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ, Baden LR, Morrissey S. Rubin EJ, et al. N Engl J Med. 2020 May 28;382(22):e94. doi: 10.1056/NEJMe2019975. N Engl J Med. 2020. PMID: 32459948 No abstract available.
Liver injury in remdesivir-treated COVID-19 patients.
Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, De Rosa R, Corcione A, Durante-Mangoni E. Zampino R, et al. Hepatol Int. 2020 Sep;14(5):881-883. doi: 10.1007/s12072-020-10077-3. Epub 2020 Jul 28. Hepatol Int. 2020. PMID: 32725454 Free PMC article. No abstract available.
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9. Trials. 2020. PMID: 32448345 Free PMC article.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Spinner CD, et al. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence].
Di Pasquale G, Maggioni AP. Di Pasquale G, et al. G Ital Cardiol (Rome). 2020 Jul;21(7):479-482. doi: 10.1714/3386.33632. G Ital Cardiol (Rome). 2020. PMID: 32555562 Review. Italian. No abstract available.
BET 1: The role of remdesivir in COVID-19 infection.
Baombe JP. Baombe JP. Emerg Med J. 2020 Aug;37(8):522-523. doi: 10.1136/emermed-2020-210336.02. Emerg Med J. 2020. PMID: 32753375 Free PMC article.
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.
Humeniuk R, Mathias A, Cao H, Osinusi A, Shen G, Chng E, Ling J, Vu A, German P. Humeniuk R, et al. Clin Transl Sci. 2020 Sep;13(5):896-906. doi: 10.1111/cts.12840. Epub 2020 Aug 5. Clin Transl Sci. 2020. PMID: 32589775 Free PMC article. Clinical Trial.
Remdesivir, a remedy or a ripple in severe COVID-19?
Doggrell SA. Doggrell SA. Expert Opin Investig Drugs. 2020 Nov;29(11):1195-1198. doi: 10.1080/13543784.2020.1821645. Epub 2020 Sep 20. Expert Opin Investig Drugs. 2020. PMID: 32896184 Free PMC article.
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Durante-Mangoni E, Andini R, Bertolino L, Mele F, Florio LL, Murino P, Corcione A, Zampino R. Durante-Mangoni E, et al. Infection. 2020 Oct;48(5):779-782. doi: 10.1007/s15010-020-01448-x. Epub 2020 May 16. Infection. 2020. PMID: 32418190 Free PMC article.
156 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback